Hiroyasu Iwase
About Hiroyasu Iwase
Hiroyasu Iwase is an Associate Director at Insmed Incorporated, with extensive experience in clinical research across several pharmaceutical companies in Japan. He has held various roles at organizations such as Nihon Schering K.K., Kyowa Kirin Co., Ltd., and The Janssen Pharmaceutical Companies of Johnson & Johnson.
Current Role at Insmed
Hiroyasu Iwase serves as Associate Director at Insmed Incorporated, a position he has held since 2021. In this role, he contributes to the strategic direction and operational management of clinical research initiatives within the company. His experience in the pharmaceutical industry enhances Insmed's capabilities in developing innovative therapies.
Previous Experience in Pharmaceutical Industry
Prior to his current role, Hiroyasu Iwase accumulated extensive experience in the pharmaceutical sector. He worked at Nihon Schering K.K. as a Clinical Research Associate from 2002 to 2005. He then joined Kyowa Kirin Co., Ltd. as a Manager and Clinical Research Associate from 2005 to 2013. Following this, he served as Manager at NanoCarrier Ltd. from 2013 to 2017 and as Group Manager and Associate Director at The Janssen Pharmaceutical Companies of Johnson & Johnson in 2017-2018.
Educational Background in Pharmacy
Hiroyasu Iwase earned a Bachelor's degree in Pharmacy from Meiji Pharmaceutical University, where he studied from 1993 to 1997. This educational foundation provided him with the knowledge and skills necessary for his career in clinical research and pharmaceutical development.
Career Timeline Overview
Hiroyasu Iwase's career spans over two decades in the pharmaceutical industry. He began his professional journey at Yakult Honsha Co., Ltd. from 1997 to 2002. He then transitioned to Nihon Schering K.K. for three years, followed by an eight-year tenure at Kyowa Kirin Co., Ltd. After four years at NanoCarrier Ltd., he briefly worked at The Janssen Pharmaceutical Companies before joining Insmed in 2021.